相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Invariant NKT cells inhibit development of the Th17 lineage
Lennart T. Mars et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells
Hans J. P. M. Koenen et al.
BLOOD (2008)
Th17 cell differentiation: The long and winding road
Mandy J. McGeachy et al.
IMMUNITY (2008)
Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category
Dror Luger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Host T cells are the main producers of IL-17 within the central nervous system during initiation of experimental autoimmune encephalomyelitis of Th1 cell lines
Jason R. Lees et al.
JOURNAL OF IMMUNOLOGY (2008)
Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells
Georg H. Stummvoll et al.
JOURNAL OF IMMUNOLOGY (2008)
Activation of invariant NKT cells ameliorates experimental ocular autoimmunity by a mechanism involving innate IFN-γ production and dampening of the adaptive Th1 and Th17 responses
Rafael S. Grajewski et al.
JOURNAL OF IMMUNOLOGY (2008)
被撤回的出版物: Reprogrammed FoxP3+ T regulatory cells become IL-17+ antigen-specific autoimmune effectors in vitro and in vivo (Retracted article. See vol. 184, pg. 6556, 2010)
Suresh Radhakrishnan et al.
JOURNAL OF IMMUNOLOGY (2008)
Invariant NKT cells regulate experimental autoimmune encephalomyelitis and infiltrate the central nervous system in a CD1d-independent manner
Lennart T. Mars et al.
JOURNAL OF IMMUNOLOGY (2008)
The inflamed central nervous system drives the activation and rapid proliferation of Foxp3+ regulatory T cells
Richard A. O'Connor et al.
JOURNAL OF IMMUNOLOGY (2007)
Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid
Daniel Mucida et al.
SCIENCE (2007)
TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1
Ahjoku Amadi-Obi et al.
NATURE MEDICINE (2007)
Autoimmune uveitis elicited with antigen-pulsed dendritic cells has a distinct clinical signature and is driven by unique effector mechanisms: Initial encounter with autoantigen defines disease phenotype
Jun Tang et al.
JOURNAL OF IMMUNOLOGY (2007)
Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease
Jens Lohr et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
TGF-β-mediated suppression by CD4+CD25+ T cells is facilitated by CTLA-4 signaling
Takatoku Oida et al.
JOURNAL OF IMMUNOLOGY (2006)
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
E Bettelli et al.
NATURE (2006)
DX5+NKT cells induce the death of colitis-associated cells:: involvement of programmed death ligand-1
M Hornung et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages
LE Harrington et al.
NATURE IMMUNOLOGY (2005)
CD8 bright CD56+ T cells are cytotoxic effectors in patients with active Behcet's uveitis
JK Ahn et al.
JOURNAL OF IMMUNOLOGY (2005)
Negative feedback regulation of T helper type 1 (Th1)/Th2 cytokine balance via dendritic cell and natural killer T cell interactions
K Minami et al.
BLOOD (2005)
Inhibition of T cell differentiation into effectors by NKT cells requires cell contacts
J Novak et al.
JOURNAL OF IMMUNOLOGY (2005)
Direct regulatory role of NKT cells in allogeneic graft survival is dependent on the quantitative strength of antigenicity
K Oh et al.
JOURNAL OF IMMUNOLOGY (2005)
Toward an understanding of NKT cell biology: Progress and paradoxes
M Kronenberg
ANNUAL REVIEW OF IMMUNOLOGY (2005)
Suppression of collagen-induced arthritis by natural killer T cell activation with OCK a sphingosine-truncated analog of alpha-galactosylceramide
A Chiba et al.
ARTHRITIS AND RHEUMATISM (2004)
NKT cell-stimulating synthetic glycolipids as potential therapeutics for autoimmune disease
T Yamamura et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2004)
Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple sclerosis
SS Zamvil et al.
NEURON (2003)
Cutting edge:: Vα14-Jα281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice
LT Mars et al.
JOURNAL OF IMMUNOLOGY (2002)
Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis
AK Singh et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells
K Miyamoto et al.
NATURE (2001)
Cell contact-dependent immunosuppression by CD4+CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factor β
K Nakamura et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes
S Sharif et al.
NATURE MEDICINE (2001)
The natural killer T-cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice
S Hong et al.
NATURE MEDICINE (2001)
Residues 1-20 of IRBP and whole IRBP elicit different uveitogenic and immunological responses in interferon gamma deficient mice
D Avichezer et al.
EXPERIMENTAL EYE RESEARCH (2000)